Company

VetDC

VetDC, based in Fort Collins, US, develops cancer treatments for pets, focused on canine lymphoma.

About

Founded in 2009 and headquartered in Fort Collins, US, VetDC is a veterinary biotechnology company developing cancer treatments for pets, mainly canine lymphoma. Its product TANOVEA (rabacfosadine for injection) is sold to veterinary clinics. CEO Steven Roy leads the firm, which was co-founded by Terry Opgenorth. VetDC raised USD 2.5 million in Series A funding from High Country Venture and angel investors on November 24, 2014.

1Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in